Announcement

The Vanderbilt Institute of Chemical Biology (VICB) Celebrates Its 10th Anniversary!

The VICB celebrated its 10th anniversary on March 12th with a symposium that included talks by prominent investigators in the field of chemical biology, poster sessions, and more. Guest lecturers were:

Cynthia Burrows, Distinguished Professor of Organic and Biological Chemistry, University of Utah
Michael Marletta, President & CEO, The Scripps Research Institute
Paul Wender, Bergstrom Professor of Chemistry, Stanford University

Click below to view photographs of the VICB's 10th Anniversary Symposium:
Speaker Photos
Poster Session Photos 1
Poster Session Photos 2

The VICB is a trans-institutional initiative between the College of Arts and Science and the School of Medicine. The Institute's mission is to provide research and training in the application of chemical approaches to the solution of important biomedical problems.

For more information about the VICB, contact Anne Lara (anne.b.lara@vanderbilt.edu or 615-322-0907).

View Reporter Article

Agenda

Morning Session – 214 Light Hall
8:45 a.m. – 9:00 a.m. Richard McCarty, Opening Remarks
9:00 a.m. – 9:30 a.m. Michael Marletta,“From Gas Sensing to New Therapies”
9:30 a.m. – 10:00 a.m. Brian Bachmann, “Mining the Microbial Metabolome for Discovery of Antibiotics & Antibiosis” 10:00 a.m. – 10:30 a.m. Eric Skaar, “Small Molecule Modifiers of Bacterial Central Metabolism”
10:30 a.m. – 11:00 a.m. Paul Barrett, "Cholesterol Binding to the Amyloid Precursor Protein Promotes Alzheimer's Disease"

Poster Session
11:00 a.m. – 2:00 p.m. Poster Session, Robinson Breezeway

Afternoon Session – 214 Light Hall
2:00 p.m. – 2:30 p.m. Cynthia Burrows, “Nanopore Sequencing of DNA Modifications”
2:30 p.m. – 3:00 p.m. Dan Liebler, “Integrating Proteomics and Genomics to Characterize Cancer”
3:00 p.m. – 3:30 p.m. Chaz Hong, “Chemical Genetics of Vertebrate Development: Rich Ore for Future Therapies” 3:30 p.m. – 4:00 p.m. Paul Wender, "The Chemistry-Medicine Continuum: Toward Transformative Therapies for AIDS, Alzheimer’s and Resistant Cancer”